IDIvan Duran

Ivan Duran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ivan Duran has a total of 228 co-authors. Here are the top co-authors by number of shared publications:

  • Deborah Krakow

    Orthopaedic Surgery, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, USA; Human Genetics, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, USA; Obstetrics and Gynecology, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, USA

    13 shared publications
  • Daniel H. Cohn

    Department of Orthopaedic Surgery, University of California-Los Angeles, 615 Charles E. Young Drive South, BSRB 512, Los Angeles, CA 90095, United States; Department of Molecular, Cell and Developmental Biology, University of California- Los Angeles, Los Angeles, CA 90095, United States; Orthopaedic Institute for Children, University of California-Los Angeles, Los Angeles, CA 90095, United States

    7 shared publications
  • Pavel Krejci

    Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic

    7 shared publications
  • Deborah Krakow

    Department of Orthopaedic SurgeryUniversity of California Los Angeles Los Angeles California

    6 shared publications
  • Daniel H. Cohn

    Department of Molecular, Cell, and Developmental Biology, Department of Orthopaedic Surgery University of California, Los Angeles Los Angeles California USA

    5 shared publications
  • Manuel Marí-Beffa

    Grice Hutchinson Experimental Centre, Institute of Blue Biotechnology and Development (IBYDA), University of Málaga, Lomas de San Julián, 29004 Málaga, Spain

    5 shared publications

Latest Publications

  • Open Access

    Standardizing single-cell approaches to osteoarthritis: Toward a comprehensive cellular atlas

    by Ivan Delgado-Sanchez, Noe Fernandez-Pozo, Ivan Duran


  • Open Access

    Cellular stress modulates severity of the inflammatory response in lungs via cell surface BiP

    by Gustavo Rico-Llanos, Óscar Porras-Perales, Sandra Escalante, Daniel B. Vázquez-Calero, Lucía Valiente, María I. Castillo, José Miguel Pérez-Tejeiro, David Baglietto-Vargas, José Becerra, José María Reguera, et al.

    Inflammation is a central pathogenic feature of the acute respiratory distress syndrome (ARDS) in COVID-19. Previous pathologies such as diabetes, autoimmune or cardiovascular diseases become risk factors for the severe hyperinflammatory syndrome. A common feature among these risk factors is the subclinical presence of cellular stress, a finding that has gained attention after the discovery that BiP (GRP78), a master regulator of stress, participates in the SARS-CoV-2 recognition. Here, we show that BiP serum levels are higher in COVID-19 patients who present certain risk factors. Moreover, early during the infection, BiP levels predict severe pneumonia, supporting the use of BiP as a prognosis biomarker. Using a mouse model of pulmonary inflammation, we observed increased levels of cell surface BiP (cs-BiP) in leukocytes during inflammation. This corresponds with a higher number of neutrophiles, which show naturally high levels of cs-BiP, whereas alveolar macrophages show a higher than usual exposure of BiP in their cell surface. The modulation of cellular stress with the use of a clinically approved drug, 4-PBA, resulted in the amelioration of the lung hyperinflammatory response, supporting the anti-stress therapy as a valid therapeutic strategy for patients developing ARDS. Finally, we identified stress-modulated proteins that shed light into the mechanism underlying the cellular stress-inflammation network in lungs.


  • Open Access

    Cellular stress modulates severity of the acute respiratory distress syndrome in COVID-19

    by Gustavo Rico-Llanos, Óscar Porras-Perales, Sandra Escalante, Daniel Vázquez, Lucía Valiente, María I. Castillo, José Miguel Pérez-Tejeiro, David Baglietto-Vargas, José Becerra, José María Reguera, et al.

    Inflammation is a central pathogenic feature of the acute respiratory distress syndrome (ARDS) in COVID-19. Previous pathologies such as diabetes, autoimmune or cardiovascular diseases become risk factors for the severe hyperinflammatory syndrome. A common feature among these risk factors is the subclinical presence of cellular stress, a finding that has gained attention after the discovery that BiP (GRP78), a master regulator of stress, participates in the SARS-CoV-2 recognition. Here, we show that BiP serum levels are higher in COVID-19 patients who present certain risk factors. Moreover, early during the infection, BiP levels predict severe pneumonia, supporting the use of BiP as a prognosis biomarker. Using a mouse model of pulmonary inflammation, we demonstrate that cell surface BiP (cs-BiP) responds by increasing its levels in leukocytes. Neutrophiles show the highest levels of cs-BiP and respond by increasing their population, whereas alveolar macrophages increase their levels of cs-BiP. The modulation of cellular stress with the use of a clinically approved drug, 4-PBA, resulted in the amelioration of the lung hyperinflammatory response, supporting the anti-stress therapy as a valid therapeutic strategy for patients developing ARDS. Finally, we identified stress-modulated proteins that shed light into the mechanism underlying the cellular stress-inflammation network in lungs.

  • Generalization of an Active Set Newton Algorithm with Alpha-Beta divergences for audio separation

    by Auxiliadora Sarmiento Vega, Ivan Duran Diaz, Irene Fondon, Sergio Cruces

    This article considers the decomposition of a nonnegative signal into a non-negative linear combination of the contributions of pre-specified atomic units, which are also nonnegative. This model, referred as compositional model, is evident in the time-frequency characterisations of audio signals, where the sound can be viewed as a blending of spectral patterns of the component sounds that are present simultaneously. The algorithm proposed in this article obtains the activation vector of the atoms through an Active-Set Newton algorithm that employ the Alpha-Beta-divergence between the observed signal and the decomposition. This divergence family has been proved to be more efficient than other more common divergences, such as the generic Kullback-Leibler divergence in various audio signal processing applications. We have evaluated the proposed algorithm in a signal separation application of polyphonic music.


  • Open Access

    Zebrafish Models for Human Skeletal Disorders

    by Manuel Marí-Beffa, Ana B. Mesa-Román, Ivan Duran

    In 2019, the Nosology Committee of the International Skeletal Dysplasia Society provided an updated version of the Nosology and Classification of Genetic Skeletal Disorders. This is a reference list of recognized diseases in humans and their causal genes published to help clinician diagnosis and scientific research advances. Complementary to mammalian models, zebrafish has emerged as an interesting species to evaluate chemical treatments against these human skeletal disorders. Due to its versatility and the low cost of experiments, more than 80 models are currently available. In this article, we review the state-of-art of this “aquarium to bedside” approach describing the models according to the list provided by the Nosology Committee. With this, we intend to stimulate research in the appropriate direction to efficiently meet the actual needs of clinicians under the scope of the Nosology Committee.


  • Open Access

    Inflammation, a Common Mechanism in Frailty and COVID-19, and Stem Cells as a Therapeutic Approach

    by José Becerra, Ivan Duran

    As our life expectancy increases, specific medical conditions appear, and new challenges are met in terms of global health. Frailty has become a medical and scientific concept to define pathologies where inflammation, depressed immune system, cellular senescence, and molecular aging converge. But more importantly, frailty is the ultimate cause of death that limits our life span and deteriorates health in an increasing proportion of the world population. The difficulty of tackling this problem is the combination of factors that influence frailty appearance, such as stem cells exhaustion, inflammation, loss of regeneration capability, and impaired immunomodulation. To date, multiple research fields have found mechanisms participating in this health condition, but to make progress, science will need to investigate frailty with an interdisciplinary approach. This article summarizes the current efforts to understand frailty from their processes mediated by inflammation, aging, and stem cells to provide a new perspective that unifies the efforts in producing advanced therapies against medical conditions in the context of frailty. We believe this approach against frailty is particularly relevant to COVID-19, since people in a state of frailty die more frequently due to the hyperinflammatory process associated with this infection.


  • Open Access

    High Bone Mass Disorders: New Insights From Connecting the Clinic and the Bench

    by Dylan J.M. Bergen, Antonio Maurizi, Melissa M. Formosa, Georgina L.K. McDonald, Ahmed El-Gazzar, Neelam Hassan, Maria-Luisa Brandi, José A. Riancho, Fernando Rivadeneira, Evangelia Ntzani, et al.

    Monogenic high bone mass (HBM) disorders are characterized by an increased amount of bone in general, or at specific sites in the skeleton. Here, we describe 59 HBM disorders with 50 known disease-causing genes from the literature, and we provide an overview of the signaling pathways and mechanisms involved in the pathogenesis of these disorders. Based on this, we classify the known HBM genes into HBM (sub)groups according to uniform Gene Ontology (GO) terminology. This classification system may aid in hypothesis generation, for both wet lab experimental design and clinical genetic screening strategies. We discuss how functional genomics can shape discovery of novel HBM genes and/or mechanisms in the future, through implementation of omics assessments in existing and future model systems. Finally, we address strategies to improve gene identification in unsolved HBM cases and highlight the importance for cross-laboratory collaborations encompassing multidisciplinary efforts to transfer knowledge generated at the bench to the clinic. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).


  • Open Access

    Biallelic mutations in LAMA5 disrupts a skeletal noncanonical focal adhesion pathway and produces a distinct bent bone dysplasia

    by Maya Barad, Fabiana Csukasi, Michaela Bosakova, Jorge H. Martin, Wenjuan Zhang, S. Paige Taylor, Ralph S. Lachman, Jennifer Zieba, Michael Bamshad, Deborah Nickerson, et al.


  • Should we unstress SARS-CoV-2 infected cells?

    by Fabiana Csukasi, Gustavo Rico, Jose Becerra, Ivan Duran